论文部分内容阅读
１商品名Ｎｅｘｉｕｍ２ 开发与上市厂商(英）Ａｓｔｒａ Ｚｅｎｅｃａ公司于２０００年９月首次在英国上市。３ 适应证胃食管反流性疾病（ＧＯＲＤ）包括侵蚀性反流性食管炎（包括糜烂性食管炎）的起始和长期治疗，可用于食管炎的长期维持治疗和预防ＧＯＲＤ复发，以及ＧＯＲ
1 Name Nexium2 Development and Listed Vendor (UK) Astra Zeneca was first listed in the UK in September 2000. 3 Indications Gastroesophageal reflux disease (GORD) includes initial and long-term treatment of aggressive reflux esophagitis, including erosive esophagitis, long-term maintenance treatment for esophagitis and prevention of GORD recurrence, and GOR